Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stabilization notice

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURESCarnegie Investment Bank AB (”Carnegie”) notifies that stabilization measures have been undertaken in BONESUPPORT Holding AB’s (publ) (“BONESUPPORT” or the “Company”) shares traded on Nasdaq Stockholm  As announced in connection with the offering to acquire newly issued shares in the Company and the listing of the Company’s

Cxense ASA - Mandatory notification of trade and correction

Oslo, 5 July 2017. Reference is made to the stock exchange notice made by Cxense ASA (the "Company") on 1 June 2017 in connection with the Company's acquisition of 11,177 own shares and transferral of 26,177 shares to the chairman. The correct number of shares acquired 1 June 2017 was 11,777 shares. As a result, the Company’s total holding after the above transactions was 600 treasury shares.   The Company has today sold 600 shares in the Company at an average price of NOK 82.00 per share, resulting in the Company holding a total of 0 treasury shares. Investor Relations Contact:

Axactor secures additional funding for NPL acquisitions

Oslo, 5 July, 2017 - Axactor has today signed an agreement with DNB and Nordea (the Banks) whereby the banks will make a 5th tranche available under the existing loan agreement. The 5th tranche will make another EUR 40 million available to the company, and increases the total loan facility with the Banks from EUR 120 million to EUR 160 million. This 5th tranche will be earmarked for the financing of new NPL portfolios and the Banks have agreed to allow for 100% gearing on the NPLs acquired using this tranche. Furthermore, the Banks have agreed to allow for 100% gearing on NPLs acquired

#17-629 Listing of Mini futures issued by BNP Paribas Issuance B.V.

As from July 06, 2017, 17 Mini futures issued by BNP Paribas Issuance B.V. will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB. Issuer: BNP Paribas Issuance B.V. Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from July 06, 2017 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: Africa Oil Corporation Fingerprint Cards AB ser B Genmab Getinge AB ser. B Hexagon AB ser. B Nokia Oyj

Volati’s business unit Tornum AB acquires Silokonsult Göran Persson AB

Volati’s business unit Tornum AB has today completed the acquisition of all outstanding shares in Silokonsult Göran Persson AB – a Swedish supplier of machinery and planning for the grain and milling industries.The acquisition of Silokonsult Göran Persson AB will strengthen Tornum’s position as a leading supplier of grain processing equipment for industrial customers in Sweden. Revenues for the fiscal year ending in April 2017 amounted to approximately SEK 60 million. The revenue and the profit for last fiscal year was positively affected by a larger project. Due to the project-based nature

Etteplan OYJ: SHARE REPURCHASE 5.7.2017

Released:7/5/2017Category:Changes in company's own sharesEtteplan OyjChanges in company's own shares Helsinki, Finland, 2017-07-05 17:30 CEST (GLOBE NEWSWIRE) -- Etteplan Oyj ANNOUNCEMENT 5.7.2017Etteplan OYJ: SHARE REPURCHASE 5.7.2017In the Helsinki Stock ExchangeTrade date 5.7.2017Bourse trade BuyShare ETTEAmount 600 SharesAverage price/ share 9,0967 EURTotal cost 5 458,02 EUREtteplan Oyj now holds a total of 48 147 sharesincluding the shares repurchased on 5.7.2017On behalf of Etteplan OyjNordea Bank AB (publ), Finnish BranchJanne Sarvikivi Julius

China Telecom and Ericsson launch open IoT platform

· Global connection management platform will support China’s “One Belt One Road” strategy and accelerate the deployment of IoT solutions and services · China Telecom IoT Open Platform enables enterprise customers to deploy, manage and scale IoT connected devices and applications globally · Based on Ericsson Device Connection Platform, part of Ericsson’s IoT Accelerator, used by more than 25 operators and supports over 2,000 enterprise customersChina Telecom and Ericsson (NASDAQ: ERIC) have launched the China Telecom IoT Open Platform – a global connection management platform that will

Veidekke ASA: Humlegården awards Arcona contract

Veidekke subsidiary Arcona has been commissioned by Humlegården Fastigheter AB to carry out the contract in Humlegården's development project in the Riddaren district at Östermalm in Stockholm.  The project is a turnkey contract valued at approx. SEK 400 million. For press photos, see www.flickr.com/photos/veidekke, for more information, contact:Arcona AB: Jeanette Saveros, CEO, jeanette.saveros@arcona.se tel. +46 8 601 21 22Humlegården Fastigheter AB: Maria Lidström, Director of Investment and Development, maria.lidstrom@humlegarden.se tel. +46 8-678 90 64Veidekke ASA: Jørgen

Positive news concerning the pharmaceutical product Eletriptan EQL Pharma

The pharmaceutical product Eletriptan EQL Pharma was approved Monday within the framework of a decentralized procedure (a common approval procedure used when more than one country is involved). National approvals for Sweden and Denmark are expected within approximately a month. Eletriptan EQL Pharma belongs to a group of medicines called Selective Serotonin receptor (5HT1) agonists. Eletriptan is used to treat migraine headache with or without aura in adults. The total turnover in Sweden and Denmark is approximately 15 MSEK annually. In Denmark, there are two generic competitors on

NPRO: INVITATION TO PRESENTATION OF SECOND QUARTER 2017

Norwegian Property ASA (OSE: NPRO, NPRO.OL) releases its second quarter results on Wednesday 12 July 2017, and we are pleased to invite investors, analysts and media to a presentation of the results. The presentation will be held by Svein Hov Skjelle (CEO).Date: Wednesday 12 July 2017Time: 08:30 a.m. Central European TimeLocation: Høyres Hus, Stortingsgt. 20, OsloThe presentation will also be broadcasted live via webcast. The webcast may be followed from: http://webtv.hegnar.no/presentation.php?webcastId=58374157

#17-308 Listing of Knock out warrants issued by Commerzbank AG

As from July 06, 2017, 2 Knock out warrants issued by Commerzbank AG will be listed on NDX Finland and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Finland Oy. Issuer: Commerzbank AG Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from July 06, 2017 and forward or until time for knock out event Market Maker: Commerzbank AG Underlying: DAX 30 Index Current values of strike and barrier can be found at: [ NGM Market Data Web - KnockOutWarrants ] 

#17-628 Listing of Constant Leverage Certificates issued by SG Issuer

As from July 06, 2017, 2 Constant Leverage Certificates issued by SG Issuer will be listed on NDX Sweden and will be included on the list for Certificates. The instruments will be registered at Euroclear Sweden AB. Issuer: SG Issuer Type of security: Call and put Certificates Execution: Automatic cash settlement Term: As from July 06, 2017, open ended Market Maker: Societe Generale Underlying: ICE Brent Crude Oil Futures For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at

#17-627 Listing of Mini futures issued by BNP Paribas Issuance B.V.

As from July 06, 2017, 2 Mini futures issued by BNP Paribas Issuance B.V. will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB. Issuer: BNP Paribas Issuance B.V. Type of security: Mini futures, open ended Execution: Automatic cash settlement Term: As from July 06, 2017 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: Gold (troy ounce) Silver (troy ounce) Current values of strike and barrier can be found at: [ NGM Market Data Web -

#17-626 Listing of Knock out warrants issued by BNP Paribas Issuance B.V.

As from July 06, 2017, 11 Knock out warrants issued by BNP Paribas Issuance B.V. will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB. Issuer: BNP Paribas Issuance B.V. Type of security: Knock out warrants, open ended Execution: Automatic cash settlement Term: As from July 06, 2017 and forward or until time for knock out event Market Maker: BNP Paribas Arbitrage SNC Underlying: AstraZeneca PLC Boliden AB Telefonaktiebolaget LM Ericsson ser. B SKF AB ser. B SSAB AB ser. A

Nel ASA: Mandatory notification of trade

(Oslo, July 5, 2017) Hanne Skaarberg Holen, chair of the board of directors in Nel ASA ("Nel") has on July 5, 2017 purchased 200,000 shares in Nel at NOK 2.25 per share.  After the transaction, Hanne Skaarberg Holen has a holding of 200,000 shares in Nel, representing approx. 0.02% of the total number of shares in Nel (based on 898,835,675 outstanding shares). ENDS For additional information, please contact: Bent Skisaker, CFO , +47 4682 1393  About Nel| www.nelhydrogen.com       Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and

Collaboration and office flow - the perks of ABW!

In an activity-based office, the employees do not have fixed work desks. Instead they are more mobile and encouraged to work from different parts of the office. This way of working aims to reduce annoying friction and create dynamic work environments that suit the wide spectra of the staff’s work activities, whether it is developing new ideas, delivering content or sharing knowledge. One can therefore say that an ABW environment is adapted to fit individual needs.  This modern way of working is however not only beneficial for the employees, but has been proven as extremely profitable for

Stora Enso divests the rigid paperboard business Re-board in Sweden

STORA ENSO OYJ STOCK EXCHANGE RELEASE 5 July 2017 at 15.00 EESTStora Enso has today signed an agreement to divest the business and assets of its Swedish subsidiary Stora Enso Re-board AB, a producer of rigid paperboard for expositions and displays, to Culas AB, which is partially owned by the current managing director of Stora Enso Re-board AB, John-Åke Svensson. “Stora Enso’s focus within packaging is on developing and delivering fibre-based solutions throughout the value chain. Re-board delivers a niche product and we believe that a new owner can better give this business the attention

Instalco grows in the Oslo region through the acquisition of AS Elektrisk

Instalco strengthens its offering in Oslo through the acquisition of AS Elektrisk, a total contractor in electrical and telecom installation services with strong local connections in the region.AS Elektrisk was founded by Trond Brustad and Arne Fjell in 1983, and currently has some 40 employees. The acquisition strengthens Instalco’s offering in Oslo and complements the previous acquisitions of the electrical installation companies Romerike Elektro and AR Elektroprosjekt. In 2016, the company’s sales amounted to approximately NOK 64 million with good profitability. “AS Elektrisk is a

FDA grants SOBI003 Orphan Drug Designation for the treatment of MPS IIIA

Swedish Orphan Biovitrum AB (publ)  (Sobi™) has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the company’s development candidate SOBI003, a chemically modified human recombinant sulfamidase for the treatment of mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A, a rare metabolic disorder. “We are very pleased with the orphan drug designation from the FDA for SOBI003. MPS IIIA is a severe and debilitating disease, and this development program is an important part of our mission of

Silvestica Green Forest Finland acquires 6,877 ha forestry land from UPM

(UPM, Helsinki, 5 July 2017 at 14:00 EET) - UPM has signed a contract to sell forest estates to Silvestica Green Forest Finland Oy. The contract covers 6,877 hectares of forestry land located in Kajaani, Sonkajärvi and Sotkamo in Finland. In addition, the parties have signed a separate long-term wood purchase and forest management agreement. Silvestica Green Forest Finland Oy is committed to certify the estates according to FSC[®] and to join the UPM managed FSC group certificate (FSC C 109750). For the time being the estates are PEFC[TM] certified. The parties have agreed not to disclose

Indutrade acquires Wennerström Ljuskontroll AB

Indutrade today signed an agreement to acquire all of the shares in Wennerström Ljuskontroll AB, Sweden, (www.wlk.eu), with annual sales of approximately SEK 110 million. WLK is a technology sales company specialising in lighting components and light control. The offering includes lighting controls, LED lightsources & drivers, and components for lighting luminaires. Customers consist of lighting luminaire manufacturers, electrical wholesalers, electrical contractors, and property owners.  Possession takes place today and the company will be part of Indutrade’s Industrial Components

Information on Intrum Justitia’s interim report January-June 2017

Intrum Justitia hereby announce the following related to its Q2-2017 interim report: · The report will be published on July 25 at 7 AM CET, one week later than previously planned. The delayed reporting is a result of the merger with Lindorff occuring very late in June, requiring a slightly extended financial reporting process. Dial--in details for the audiocast will be provided on July 14. · As a consequence of the merger occuring close to June 30, the reported profit and loss will consist of Intrum Justita’s financials without contributions from Lindorff units. In order to provide

Successful completion of Phase I and initiation of Phase IIa clinical trial of a universal malaria vaccine produced in ExpreS2

Horsholm, Denmark, July 5, 2017 – Today, ExpreS2ion Biotech Holding AB announces that the Jenner Institute of the University of Oxford, a licensee of the fully owned subsidiary ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), initiates recruiting for a Phase IIa clinical trial following a successful Phase I safety study of its new blood stage malaria vaccine. The Phase IIa trial will assess safety, immunogenicity and efficacy of the blood-stage malaria vaccine, which is produced in ExpreS2ion’s proprietary platform, Expres2. Malaria is causing more than 400,000 deaths annually, and the vaccine

There are no items matching the current filter
There are no more items matching the current filter
Back to top